Despina Moshous Selected Research

Biomarkers (Surrogate Marker)

1/2022	Inborn errors of immunity caused by defects in the DNA damage response pathways: Importance of minimizing treatment-related genotoxicity.
1/2019	PROMIDISα: A T-cell receptor α signature associated with immunodeficiencies caused by V(D)J recombination defects.
1/2017	Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Despina Moshous Research Topics

Disease

14	Infections 10/2022 - 04/2009
8	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 01/2006
6	Chronic Granulomatous Disease 01/2021 - 09/2010
6	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020 - 03/2007
5	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2021 - 01/2014
4	Cytopenia 01/2022 - 01/2018
4	Granuloma 01/2019 - 10/2011
3	Primary Immunodeficiency Diseases 10/2022 - 01/2019
3	Colitis 10/2022 - 01/2017
3	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 10/2018
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2020 - 01/2016
3	Rubella (German Measles) 01/2019 - 01/2017
3	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2019 - 09/2008
3	Lymphopenia (Lymphocytopenia) 11/2018 - 01/2016
2	Lung Diseases (Lung Disease) 10/2022 - 01/2017
2	Neoplasms (Cancer) 10/2022 - 01/2017
2	Evans Syndrome 01/2022 - 07/2019
2	Immune System Diseases (Immune Disorders) 01/2022 - 07/2009
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2022 - 01/2019
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 07/2019
2	Subcutaneous panniculitis-like T-cell lymphoma 01/2020 - 12/2018
2	Rare Diseases (Rare Disease) 01/2020 - 01/2018
2	Hemolysis 01/2020 - 12/2017
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019 - 11/2004
2	Thalassemia 01/2018 - 01/2018
2	DiGeorge Syndrome (Syndrome, DiGeorge) 12/2017 - 10/2012
1	Bronchiectasis 10/2022
1	Activated PI3K-delta Syndrome 01/2022
1	Wiskott-Aldrich Syndrome 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Leukocyte adhesion deficiency type 1 12/2021
1	Hemorrhage 12/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Osteopetrosis 01/2021
1	Bruton type agammaglobulinemia 01/2021
1	Eczema 01/2021
1	Arthritis (Polyarthritis) 12/2020
1	Dizziness (Lightheadedness) 12/2020
1	Psychomotor Agitation (Akathisia) 12/2020
1	Aphthous Stomatitis (Aphthous Ulcer) 12/2020
1	Disease Progression 12/2020
1	Arthralgia (Joint Pain) 12/2020
1	Chemical and Drug Induced Liver Injury 12/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020
1	Pneumothorax 01/2020
1	Skin Manifestations 01/2020
1	Systemic Vasculitis 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Liver Failure 01/2020
1	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 01/2020
1	Pulmonary Hypertension 11/2019
1	Neutropenia 07/2019
1	Nijmegen Breakage Syndrome 01/2019

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	EnzymesIBA 12/2020 - 04/2012
3	SteroidsIBA 01/2020 - 07/2019
3	VaccinesIBA 01/2019 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2018 - 12/2013
2	LigandsIBA 01/2022 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2016
2	Immunoglobulin E (IgE)IBA 01/2021 - 11/2018
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 12/2018
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 05/2017
2	InflammasomesIBA 05/2017 - 09/2010
2	Immunoglobulin M (IgM)IBA 01/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2017
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2014 - 09/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2021
1	PhosphoglucomutaseIBA 01/2021
1	seletalisibIBA 12/2020
1	NucleosidesIBA 12/2020
1	Cladribine FDA LinkGeneric 12/2020
1	Dextran SulfateIBA 11/2020
1	SaltsIBA 11/2020
1	Brentuximab VedotinIBA 01/2020
1	ruxolitinibIBA 01/2020
1	PorphyrinsIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2019
1	Rituximab (Mabthera)FDA Link 07/2019
1	CD40 Ligand (CD40L)IBA 01/2019

Therapy/Procedure

19	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2009
12	Therapeutics 01/2021 - 03/2007
8	Transplantation 01/2018 - 03/2007
6	Cell Transplantation 01/2022 - 01/2018
5	Stem Cell Transplantation 01/2021 - 02/2014
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2021 - 06/2015
2	Splenectomy 10/2022 - 01/2022
1	Antibiotic Prophylaxis 01/2021
1	Organ Transplantation 01/2020
1	Lung Transplantation 01/2020
1	Central Venous Catheters 10/2019